BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28038941)

  • 41. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
    Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
    Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies.
    Sabt A; Abdelhafez OM; El-Haggar RS; Madkour HMF; Eldehna WM; El-Khrisy EEAM; Abdel-Rahman MA; Rashed LA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1095-1107. PubMed ID: 29944015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
    Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
    Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
    Han T; Tian K; Pan H; Liu Y; Xu F; Li Z; Uchita T; Gao M; Hua H; Li D
    Eur J Med Chem; 2018 Apr; 150():53-63. PubMed ID: 29524728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
    Liu CF; Shen QK; Li JJ; Tian YS; Quan Z
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
    Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
    Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis.
    Mohammed HHH; Abbas SH; Hayallah AM; Abuo-Rahma GEA; Mostafa YA
    Bioorg Chem; 2021 Jan; 106():104422. PubMed ID: 33248713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and Cytotoxic Evaluation of Pyran, Dihydropyridine and Thiophene Derivatives of 3-Acetylcoumarin.
    Mohareb RM; Megally Abdo NY
    Chem Pharm Bull (Tokyo); 2015; 63(9):678-87. PubMed ID: 26329861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents.
    Yang J; Liu GY; Dai F; Cao XY; Kang YF; Hu LM; Tang JJ; Li XZ; Li Y; Jin XL; Zhou B
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6420-5. PubMed ID: 21920747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and preliminary antiproliferative activity studies of new diheteroaryl thioether derivatives.
    Li ZH; Liu XQ; Zhao TQ; Geng PF; Liu Y; Zhao B; Guo WG; Yu B; Liu HM
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4377-4382. PubMed ID: 28838695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
    Wang Y; Zhang W; Dong J; Gao J
    Bioorg Chem; 2020 Jan; 95():103530. PubMed ID: 31887477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF; Hassaneen HM; Abdelhamid IA
    Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents.
    Goud NS; Pooladanda V; Mahammad GS; Jakkula P; Gatreddi S; Qureshi IA; Alvala R; Godugu C; Alvala M
    Chem Biol Drug Des; 2019 Sep; 94(5):1919-1929. PubMed ID: 31169963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer Activity Study of Chromone and Coumarin Hybrids using Electrical Impedance Spectroscopy.
    Bouhenna MM; Mameri N; Pérez MV; Talhi O; Bachari K; Silva AMS; Luyten W
    Anticancer Agents Med Chem; 2018; 18(6):854-864. PubMed ID: 29380706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation.
    El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; F Kassem A
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Coumarin-Containing Aminophosphonatesas Antitumor Agent: Synthesis, Cytotoxicity, DNA-Binding and Apoptosis Evaluation.
    Li YJ; Wang CY; Ye MY; Yao GY; Wang HS
    Molecules; 2015 Aug; 20(8):14791-809. PubMed ID: 26287139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226.
    Ashour HF; Abou-Zeid LA; El-Sayed MA; Selim KB
    Eur J Med Chem; 2020 Mar; 189():112062. PubMed ID: 31986406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
    Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
    Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.